One-third of patients with leukemic transformation from Philadelphia chromosome–negative myeloproliferative neoplasms survived for long-term
The largest number of umbilical cord blood transplantations for leukemic transformation from Philadelphia chromosome–negative myeloproliferative neoplasms was included in this study
Umbilical cord blood transplantation provided 25% of 2-year overall survival for patients not in remission